Relationship between dose of antithyroid drugs and adverse events in pediatric patients with Graves’ disease

Graves’ disease (GD) accounts for a large proportion of pediatric hyperthyroidism, and the first-line treatment is antithyroid drug (ATD) therapy. Methimazole (MMI) is effective in most patients but is associated with significant adverse events (AEs). We reviewed the medical records of GD patients (...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Pediatr Endocrinol
Auteurs principaux: Yasuda, Kie, Miyoshi, Yoko, Tachibana, Makiko, Namba, Noriyuki, Miki, Kazunori, Nakata, Yukiko, Takano, Toru, Ozono, Keiichi
Format: Artigo
Langue:Inglês
Publié: The Japanese Society for Pediatric Endocrinology 2017
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5295245/
https://ncbi.nlm.nih.gov/pubmed/28203042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1297/cpe.26.1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires